Traditional pharmaceutics and therapies do not allow early and reliable diagnosis of malignant tumors and do not guarantee that a therapy optimal for each specific patient is prescribed. Traditional anticancer drugs and therapies fail to ensure full recovery of patients at late oncogenesis stages. Therefore, search for new anticancer drugs and development of their application strategies is in progress. Among recent findings we could mention magnetically controlled therapeutic and diagnostic nanopreparations (MNPs), techniques for tumor visualization and contrast agents for tumor diagnosis, as well as techniques for drug delivery to damaged cells and therapy [1-10].
展开▼
